Tandutinib is an oral tyrosine kinase inhibitor designed to target KIT and PDGFRA receptors, which are involved in signaling pathways that drive tumor cell growth and survival in gastrointestinal stromal… Read more
Tandutinib is an oral tyrosine kinase inhibitor designed to target KIT and PDGFRA receptors, which are involved in signaling pathways that drive tumor cell growth and survival in gastrointestinal stromal tumors and other malignancies. This category offers high-quality reference standards for the Tandutinib active pharmaceutical ingredient, as well as a comprehensive selection of its related impurities, metabolites, and stable isotope-labelled compounds. These compounds are essential for laboratories conducting critical analytical procedures, including impurity profiling, method validation, and rigorous quality control testing. By utilizing these precise analytical standards, researchers and quality assurance professionals can ensure the accuracy of quantification and maintain regulatory compliance throughout the drug development and manufacturing lifecycle. These materials facilitate reliable performance in identifying degradation products and monitoring therapeutic substances in complex matrices.